Advertisement
BD Biosciences
BD Biosciences

The Scientist

» patent

Most Recent

image: “Heroes of CRISPR” Disputed

“Heroes of CRISPR” Disputed

By | January 19, 2016

Critics have harsh words for the Broad Institute’s Eric Lander and Cell over a recent perspective piece describing the history of CRISPR.

10 Comments

image: Who Owns CRISPR, Cont’d

Who Owns CRISPR, Cont’d

By | January 14, 2016

The US Patent and Trademark Office declares a patent “interference” and will seek to determine who has rights to the gene-editing technology.

1 Comment

image: TS Picks: CRISPR Patent Edition

TS Picks: CRISPR Patent Edition

By | January 5, 2016

A challenge to the first CRISPR patent just got teeth.

3 Comments

image: Who Owns CRISPR?

Who Owns CRISPR?

By | April 3, 2015

With one US patent awarded and many other applications under consideration for the popular genome-editing technology, companies are adopting multiple strategies to navigate the complex intellectual property landscape.

6 Comments

American universities top a list of educational institutions ranked according to their number of international patent applications.

0 Comments

image: Myriad Settles Suit

Myriad Settles Suit

By | January 26, 2015

The Utah-based firm has settled its lawsuit claiming patent infringement against Pathway Genomics.

0 Comments

image: Merck Buys Cubist for $8.4B

Merck Buys Cubist for $8.4B

By | December 11, 2014

Hours after the pharmaceutical giant announced the acquisition, a federal judge invalidated key patents behind the antibiotic maker’s most lucrative product.

0 Comments

image: Keeping Up with IP

Keeping Up with IP

By | September 1, 2014

It’s never too early to start thinking about intellectual property rights—even for biologists doing basic research.

0 Comments

image: Patent Plea Ping Pong

Patent Plea Ping Pong

By | August 21, 2014

A genetic testing firm accused of infringing upon Myriad Genetics’s gene patents fights back in an attempt to wipe other patents out.

1 Comment

image: Yet Another Lawsuit over Genetic Tests

Yet Another Lawsuit over Genetic Tests

By | June 17, 2014

Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing another competitor for patent infringement.

0 Comments

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  3. Biologist Resigns Amid Sexual Misconduct Probe
  4. Turning Tumor Cells Against Cancer
Advertisement
Advertisement
Life Technologies